Glenmark Pharmaceuticals Inc., USA Recall: Fulvestrant Injection 250 mg/5 mL (50 mg/mL) Fo
Glenmark Pharmaceuticals Inc., USA Recall: Fulvestrant Injection 250 mg/5 mL (50 mg/mL) Fo is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Glenmark Pharmaceuticals Inc., USA; Product: Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-fil
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
|---|---|
| Product | Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide. |
| Recall initiated | 20210827 |
| Recall number | D-0820-2021 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →